Christopher Plescia

6 papers receiving 420 citations

Hit Papers

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity 2020 · 326 citations
3262020202620222024100200300

Peers

Christopher Plescia
Comparison fields: 5 of 52
  • Biotechnology 175
  • Immunology 100
  • Biomedical Engineering 147
  • Biological Psychiatry 8
  • Hepatology 23
Replace Kenia de los Santos-Alexis with:
Kenia de los Santos-Alexis United States
Hanrui Wu South Africa
Marie‐Ève Lebel Canada
Daoyuan Xie China
Djenet Bousbaine United States
Igor V. Deyneko Germany
Nadine Kasnitz Germany
Simon Rajendran Ireland
Sreyan Chowdhury United States
Arthee Jahangir United States
Christopher Plescia relative to Kenia de los Santos-Alexis United States Kenia de los Santos-Alexis's profile →
Citations per field
00.5×2.9×
Kenia de los Santos-Alexis · 1×
Citations per year

Countries citing papers authored by Christopher Plescia

Since Specialization
Citations

This map shows the geographic impact of Christopher Plescia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Plescia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Plescia more than expected).

Fields of papers citing papers by Christopher Plescia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Plescia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Plescia. The network helps show where Christopher Plescia may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Plescia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Plescia Line = papers co-authored together Christopher Plescia links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Hit paper breakdown →
2020326
2 201752
3 200140
4 20244
5 20153
6 20213
7 20151

About Christopher Plescia

Christopher Plescia is a scholar working on Hepatology, Biotechnology, Molecular Biology, Genetics and Epidemiology, having authored 7 papers that have together received 429 indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Virus-based gene therapy research (2 papers), Pancreatic function and diabetes (1 paper), Viral Infections and Outbreaks Research (1 paper), Cervical Cancer and HPV Research (1 paper) and Chromatin Remodeling and Cancer (1 paper). The work is most often cited by research in Biotechnology (175 citations), Immunology (100 citations), Biomedical Engineering (147 citations), Biological Psychiatry (8 citations) and Hepatology (23 citations). Christopher Plescia has collaborated with scholars based in United States. Frequent co-authors include Ning Li, Munira Momin, Adam Fisher, Kip A. West, Daniel S. Leventhal, Starsha Kolodziej, Jianrong Gao, Paul Miller, Rudy Christmas and Anna Sokolovska. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Differentiation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026